Studies how patients take part in atopic dermatitis research
Looks at how many people finish atopic dermatitis trials and who leaves early.
Plain-language title generated from the registry record
Registry title: Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials
Key facts
- Where
- San Francisco, United StatesSee the site
Where in United States
- Power Life SciencesSan Francisco, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Power Life Sciences Inc.
- Trial code
- NCT06174493
- Record updated
- 12 February 2024
- Original description
Clinical trials, specifically focused on atopic dermatitis, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.Read full original descriptionShow less
Understanding Patient Engagement Trends in Atopic Dermatitis Clinical Research
Clinical trials, specifically focused on atopic dermatitis, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.
The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.
Inclusion: Ability to understand and the willingness to sign a written informed consent document; Participant must be 18 years of age or older; Confirmed diagnosis of atopic dermatitis.
Exclusion: Enrolled in another research study; Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study; Inability to provide written informed consent.